Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neutropenia 1Hematologic Neoplasms 1

Interventions

trifluridine tipiracil drug combination 2pegylated granulocyte colony-stimulating factor 2trilaciclib 1plerixafor 1eravacycline 1Vancomycin 1Teicoplanin 1PM 01183 1Ofloxacin 1Metronidazole 1Meropenem 1Loratadine 1Levofloxacin 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Bevacizumab 1Amikacin 1Algorithms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neutropenia × eravacycline × 1 year × Clear all
NCT05537896 2026-04-16

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

West Virginia University

Phase 2 Recruiting
55 enrolled
Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡